Actively Recruiting
Personalized-Target Transcranial Magnetic Stimulation TMS Treatment for Adults with Chronic Tinnitus A Single-Center, Single-Blind Randomized Clinical Trial Comparing Personalized vs Conventional TMS
Led by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Updated on 2025-12-05
116
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of personalized-target transcranial magnetic stimulation TMS for treating chronic subjective tinnitus. The study compares stimulation directed at individualized auditory cortex targets identified by resting-state functional MRI with conventional TMS targeting. The goal is to find out whether personalized targeting provides better relief from tinnitus symptoms and is well-tolerated by patients. This clinical trial is randomized and single-blind, involving 116 participants with chronic tinnitus. Participants will be randomly assigned to one of two groups. One group receives continuous theta burst stimulation cTBS aimed at the auditory cortex region with the strongest connection to the parahippocampal gyrus, pinpointed by resting-state fMRI. The other group receives cTBS at a standard auditory cortex site CP5 used in previous tinnitus studies. Each participant undergoes three sessions daily, with 600 pulses per session, totaling 1,800 pulses per day, for five consecutive days. During the trial, participants will complete several assessments, including tinnitus severity, anxiety, depression, and sleep quality, measured at baseline, after treatment, and at 1- and 3-month follow-ups. Researchers will also monitor brain activity changes using EEG and MRI scans. The primary outcome is the rate of tinnitus relief five days after treatment. Safety, adherence, and factors predicting response to personalized TMS will also be evaluated. Total participation spans from enrollment through the 3-month follow-up period.
CONDITIONS
Brief Title
Efficacy Analysis of Personalized-Target Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Tinnitus: A Single-Center, Single-Blind Randomized Clinical Trial
Research Team
Y
Yuexin Cai, Doctor
Q
Qianhui Xu, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here